Lupin Europe Gmbh
Manufacturer / marketing-authorisation holder
Lupin Europe Gmbh — 11 products across 2 markets, 6 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Lupin Europe Gmbh — 11 productos en 2 mercados, 6 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Lupin Europe Gmbh —— 共 11 个产品，覆盖 2 个市场、6 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
11 products · 2 markets · 6 brand names
11 productos · 2 mercados · 6 marcas
11 个产品 · 2 个市场 · 6 个品牌名
Products by country
ES
Source: cima.aemps.es
| Brand | Active ingredient(s) | Form |
|---|---|---|
| EMTRICITABINA/TENOFOVIR ALAFENAMIDA LUPIN | Emtricitabine + 富马酸丙酚替诺福韦 | tablet |
| EMTRICITABINA/TENOFOVIR ALAFENAMIDA LUPIN | Emtricitabine + 富马酸丙酚替诺福韦 | tablet |
| FINGOLIMOD LUPIN | 盐酸芬戈莫德 | capsule |
| Namuscla 167mg capsules | 盐酸美西律 | capsule |
| Namuscla 167mg capsules | 盐酸美西律 | capsule |
| Namuscla 167mg capsules | 盐酸美西律 | capsule |
| RANLUSPEC | Ranibizumab | injection |
| RANLUSPEC PRECARGADA | Ranibizumab | injection |
EU
Source: www.ema.europa.eu
| Brand | Active ingredient(s) | Form |
|---|---|---|
| Namuscla 167mg capsules | 盐酸美西律 | unknown |
| RANLUSPEC | Ranibizumab | unknown |
| Vislyfa | Ranibizumab | unknown |